Variable
|
I
n = 20
|
II
n = 46
|
III
n = 15
|
IV
n = 9
|
Total
n = 90
|
P
|
---|
Age (yr)
|
66 (48–78)
|
68 (47–82)
|
74 (43–87)
|
69 (61–81)
|
66.0 (47.0–80.0)
|
0.959
|
Males
|
14 (70%)
|
34 (73.9%)
|
14 (93.3%)
|
7 (77.8%)
|
69 (76.7%)
|
0.393
|
APACHE II score
|
20.0 (16.5–22.0)
|
18.0 (11.8–22.0)
|
20.0 (18.0–30.0)
|
23.0 (18.0–28.5)
|
20.0 (16.0–22.0)
|
0.031a
|
SOFA score
|
6.0 (3.0–8.0)
|
5.0 (4.0–9.0)
|
6.0 (4.0–13.0)
|
8.0 (4.5–11.5)
|
6.0 (4.0–9.0)
|
0.486
|
Gastrointestinal surgery
|
1 (20%)
|
5 (10.9%)
|
1 (6.7%)
|
1 (11.1%)
|
8 (8.9%)
|
0.262
|
Primary AGI
|
3 (15%)
|
17 (37%)
|
5 (33.3%)
|
5 (55.6%)
|
30 (33.3%)
|
0.155
|
Sepsis
|
8 (40%)
|
19 (41.3%)
|
4 (26.7%)
|
4 (44.4%)
|
35 (38.9%)
|
0.760
|
Catecholamine support
|
5 (25%)
|
8 (17.4%)
|
5 (33.3%)
|
5 (55.6%)
|
23 (25.6%)
|
0.099
|
Mechanical ventilation
|
17 (85%)
|
34 (73.9%)
|
11 (73.3%)
|
9 (100%)
|
71 (78.9%)
|
0.281
|
CRRT
|
2 (10%)
|
10 (21.7%)
|
1 (6.7%)
|
1 (11.1%)
|
14 (15.6%)
|
0.421
|
Primary reason for intensive care
| | | | | |
0.131
|
Acute pancreatitis
|
1 (5%)
|
13 (28.3%)
|
5 (33.3%)
|
1 (11.1%)
|
20 (22.2%)
| |
Shock
|
3 (15%)
|
8 (17.4%)
|
1 (6.7%)
|
3 (33.3%)
|
15 (16.6%)
|
AKI
|
2 (10%)
|
10 (21.7%)
|
1 (6.7%)
|
4 (44.4%)
|
17 (18.9%)
|
ARDS
|
8 (40%)
|
14 (30.4%)
|
6 (40%)
|
5 (55.6%)
|
33 (36.7%)
|
Trauma
|
2 (10%)
|
6 (13%)
|
0
|
0
|
8 (8.9%)
|
Postoperative
|
3 (15%)
|
2 (4.3%)
|
2 (13.3%)
|
0
|
7 (7.8%)
|
Cardiac arrest
|
1 (5%)
|
1 (2.2%)
|
1 (6.7%)
|
0
|
3 (3.3%)
|
28 d-mortality
|
1 (5.0%)
|
7 (15.2%)
|
2 (13.3%)
|
4 (44.4%)
|
14 (15.6%)
|
0.067
|
- Measurement values are expressed as median (interquartile range, 25%–75%). Categorical variables are reported as n (%). Variables were compared using the Kruskal–Wallis test
-
AGI acute gastrointestinal injury, ARDS acute respiratory distress syndrome, APACHE acute physiology and chronic health evaluation, AKI acute kidney injury, CRRT continuous renal replacement therapy, SOFA sepsis-related organ failure assessment
-
aSignificant differences among AGI grades I, II, III, and IV